Drugs for preventing migraine headaches in children

  • Withdrawn
  • Review
  • Intervention


Anna Hobson, Cochrane Pain, Palliative & Supportive Care Group, Pain Research Unit, The Churchill Hospital, Old Road, Oxford, OX3 7LE, UK. anna.hobson@ndcn.ox.ac.uk.

Reason for withdrawal from publication

The original authors of this review are unable to update it. The Cochrane Pain, Palliative and Supportive Care Review Group (PaPaS) is seeking new authors to update and split the review into two separate reviews on young children (< 12 years) and adolescents (12-17 years). If you are interested, please contact the Managing Editor of PaPaS (contact details provided under 'Contact Person').

At July 2014, this review has been withdrawn. This review is out of date although it is correct as of the date of publication. The latest version is available in the ‘Other versions’ tab on The Cochrane Library, and may still be useful to readers.

The editorial group responsible for this previously published document have withdrawn it from publication.

What's new

11 July 2014AmendedThis review has been withdrawn. See Published notes.


Protocol first published: Issue 4, 2000
Review first published: Issue 4, 2003

1 October 2012AmendedContact details updated.
12 March 2012AmendedInformation about the updating of this review has been added to the Published notes section.
8 May 2008AmendedConverted to new review format.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • International Headache Society (for administrative costs associated with editorial review and peer review), Other.